Viewing Study NCT03406650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-07-06 @ 2:35 AM
Study NCT ID: NCT03406650
Status: COMPLETED
Last Update Posted: 2025-05-04
First Post: 2017-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.
Sponsor: Swiss Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None muscle invasive urothelial cancer View
None cancer View
None immunotherapy View
None durvalumab View
None MEDI4736 View
None adjuvant View
None neoadjuvant View
None radical cystectomy View
None bladder View